Guggenheim Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,415
| Closed | -$272K | – | 1842 |
|
|
2019
Q4 | $272K | Buy |
+4,415
| New | +$272K | ﹤0.01% | 1871 |
|
|
2018
Q4 | – | Sell |
-6,082
| Closed | -$344K | – | 2170 |
|
|
2018
Q3 | $344K | Buy |
6,082
+1,157
| +23% | +$65.4K | ﹤0.01% | 2159 |
|
|
2018
Q2 | $329K | Sell |
4,925
-38,965
| -89% | -$2.6M | ﹤0.01% | 2151 |
|
|
2018
Q1 | $2.56M | Buy |
43,890
+199
| +0.5% | +$11.6K | 0.01% | 1461 |
|
|
2017
Q4 | $2.82M | Sell |
43,691
-8,675
| -17% | -$559K | 0.01% | 1406 |
|
|
2017
Q3 | $2.75M | Sell |
52,366
-23
| -0% | -$1.21K | 0.01% | 1442 |
|
|
2017
Q2 | $2.45M | Sell |
52,389
-2,899
| -5% | -$136K | 0.01% | 1491 |
|
|
2017
Q1 | $2.74M | Buy |
55,288
+3,873
| +8% | +$192K | 0.01% | 1420 |
|
|
2016
Q4 | $3.12M | Buy |
51,415
+31,935
| +164% | +$1.94M | 0.01% | 1322 |
|
|
2016
Q3 | $1.29M | Sell |
19,480
-2,114
| -10% | -$140K | ﹤0.01% | 1919 |
|
|
2016
Q2 | $1.21M | Buy |
+21,594
| New | +$1.21M | ﹤0.01% | 1920 |
|
|
2016
Q1 | – | Sell |
-26,198
| Closed | -$1.18M | – | 2909 |
|
|
2015
Q4 | $1.18M | Buy |
+26,198
| New | +$1.18M | ﹤0.01% | 1999 |
|
|
2014
Q3 | – | Sell |
-65,222
| Closed | -$2.25M | – | 2950 |
|
|
2014
Q2 | $2.25M | Buy |
+65,222
| New | +$2.25M | 0.01% | 1681 |
|
|
2013
Q3 | – | Sell |
-3,761
| Closed | -$23K | – | 2999 |
|
|
2013
Q2 | $23K | Buy |
+3,761
| New | +$23K | ﹤0.01% | 2895 |
|